뉴스벤징가
Novartis Scoops up UK Biotech Myricx in $1.5 Billion Cancer Push
· 발표
기사 요약
Novartis acquires Myricx Bio for up to $1.5B to boost its oncology pipeline with a novel next-gen ADC cancer platform. Read more.
기사 원문에서 발췌했어요.뉴스 본문을 불러오고 있어요.
Novartis acquires Myricx Bio for up to $1.5B to boost its oncology pipeline with a novel next-gen ADC cancer platform. Read more.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…